STRUCTURE AND FUNCTION OF FERROCHELATASE
铁螯合酶的结构和功能
基本信息
- 批准号:2190797
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-09-30 至 1998-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This is a Shannon Award providing partial support for the research
projects that fall short of the assigned institute's funding range but
are in the margin of excellence. The Shannon Award is intended to
provide support to test the feasibility of the approach; develop further
tests and refine research techniques; perform secondary analysis of
available data sets; or conduct discrete projects that can demonstrate
the PI's research capabilities or lend additional weight to an already
meritorious application. The abstract below is taken from the original
document submitted by the principal investigator.
Heme is essential in almost every single aspect of cell function, as it
is a required prosthetic group in proteins with very diversified
functions. Ferrochelatase (protoheme ferrolyase, EC 4.99.1.1) catalyzes
the insertion of ferrous ion into protoporphyrin IX forming the product
protoheme IX and has been recognized as a key enzyme in heme biosynthesis
since 1956. Unfortunately, for the past decades, research on
ferrochelatase has been hindered by the difficultly in obtaining
sufficient quantities of purified active enzyme, in part due to the
association of ferrochelatase with membranes and the low abundance of
ferrochelatase in mitochondria. Most of our knowledge concerning the
active sites of ferrochelatase was derived from kinetic studies of
chemically modified ferrochelatase and inhibition studies. More direct
physical investigations, such as spectroscopic studies, were not possible
due to the limited availability of purified proteins. This major hurdle
has been overcome by one of our collaborators, Dr. G. C. Ferreira, who
has successfully overexpressed the murine ferrochelatase in Escherichia
coli. Most importantly, the recombinant enzyme is associated with the
bacterial soluble fraction, facilitating the subsequent purification and
manipulation of the enzyme. We now have essentially unlimited quantities
of purified active ferrochelatase for spectroscopic and kinetic studies.
Our preliminary EPR and Mossbauer spectroscopic studies of the
recombinant enzyme reveal an important and surprising result. That is,
mammalian ferrochelatase is a metalloenzyme containing a [2Fe-2S]
cluster. These new developments have opened up many new avenues for
ferrochelatase research. We therefore propose to use a combination of
spectroscopic, chemical, biochemical, and molecular biological approaches
to investigate the structure and function of ferrochelatase. In
particular, we propose (1) to apply Mossbauer, EPR and NMR spectroscopy
to characterize and to obtain structural information about the ferrous
binding site and the [2Fe-2S] cluster, (2) to identify the amino-acid
residues essential for ferrochelatase function using site-directed
mutagenesis in combination with spectroscopic and kinetic investigations,
and (3) to elucidate the mechanism of ferrochelatase employing rapid
freeze-quench EPR and Mossbauer techniques. Since ferrochelatase uses
iron as a substrate and our preliminary results established that it is
an iron-containing enzyme, the proposed spectroscopic approach, a
combination of Mossbauer and EPR techniques, is particularly suited for
the studies of ferrochelatase. The proposed investigations are expected
to yield characteristic physical properties and structural information
concerning the substrate iron binding site and the 2[Fe-2S] clusters, and
to provide detailed mechanistic information. Possible reaction
intermediates may be trapped and characterized, and its rates of
formation and decay will be determined. the proposed studies are also
expected to shed light on the functional role of the [2Fe-2S] cluster in
ferrochelatase and provide new insights in general into the role of iron
sulfur clusters in proteins.
这是一个香农奖提供部分支持的研究
项目不属于指定的研究所的资金范围,但
都处于优秀的边缘。 香农奖旨在
提供支持,以测试该方法的可行性;进一步发展
测试和完善研究技术;进行二次分析
可用的数据集;或进行离散项目,
PI的研究能力或为已经存在的
有价值的申请。 下面的摘要摘自原文
主要研究者提交的文件。
血红素在细胞功能的几乎每个方面都是必不可少的,因为它
是蛋白质中必需的辅基,
功能协调发展的 铁螯合酶(原血红素铁裂解酶,EC 4.99.1.1)催化
将二价铁离子插入原卟啉IX中形成产物
血红素IX是血红素生物合成的关键酶
从1956年开始 不幸的是,在过去的几十年里,
铁螯合酶因难以获得而受到阻碍
足够量的纯化的活性酶,部分原因是
铁螯合酶与细胞膜的结合,
线粒体中的亚铁螯合酶。 我们大多数的知识,
铁螯合酶的活性位点来自动力学研究,
化学修饰的亚铁螯合酶和抑制研究。 更直接
物理研究,如光谱研究,是不可能的,
这是由于纯化蛋白的可用性有限。 这一重大障碍
被我们的合作者G博士克服了C.费雷拉,谁
成功地在大肠杆菌中过表达鼠亚铁螯合酶
杆菌 最重要的是,重组酶与
细菌可溶性级分,便于随后的纯化,
操纵酶。 我们现在有了基本上无限的
用于光谱和动力学研究。
我们初步的EPR和穆斯堡尔谱学研究表明,
重组酶揭示了重要和令人惊讶的结果。 也就是说,
哺乳动物亚铁螯合酶是一种含有[2Fe-2S]
集群 这些新的发展开辟了许多新的途径,
铁螯合酶研究。 因此,我们建议采用以下方法
光谱、化学、生物化学和分子生物学方法
研究铁螯合酶的结构和功能。 在
特别地,我们建议(1)应用穆斯堡尔谱、EPR谱和NMR谱
以表征和获得有关铁的结构信息,
结合位点和[2Fe-2S]簇,(2)鉴定氨基酸
使用定点的铁螯合酶功能必需的残基
诱变与光谱和动力学研究相结合,
(3)用快速电泳技术阐明亚铁螯合酶的作用机理
冷冻淬火EPR和穆斯堡尔技术。 由于亚铁螯合酶使用
铁作为底物,我们的初步结果表明,它是
含铁酶、拟议的光谱方法、
穆斯堡尔和EPR技术的结合,特别适合于
铁螯合酶的研究。 预计拟议的调查将
以产生特征物理性质和结构信息
关于底物铁结合位点和2个[Fe-2S]簇,和
以提供详细的机械信息。 可能的反应
中间体可以被捕获和表征,其速率
将确定形成和衰变。 拟议的研究还
预期阐明[2Fe-2S]簇在
铁螯合酶,并提供新的见解,一般铁的作用
蛋白质中的硫簇。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Boi-Hanh V. Huynh其他文献
Boi-Hanh V. Huynh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Boi-Hanh V. Huynh', 18)}}的其他基金
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
- 批准号:
2739253 - 财政年份:1999
- 资助金额:
$ 10万 - 项目类别:
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
- 批准号:
6343059 - 财政年份:1999
- 资助金额:
$ 10万 - 项目类别:
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
- 批准号:
6490265 - 财政年份:1999
- 资助金额:
$ 10万 - 项目类别:
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
- 批准号:
6138700 - 财政年份:1999
- 资助金额:
$ 10万 - 项目类别:
Biosynthesis and Novel Functions of Fe-S Clusters
Fe-S团簇的生物合成和新功能
- 批准号:
6325357 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
NOVEL REDOX PROTEINS FROM SULFATE REDUCING BACT
来自硫酸盐还原菌的新型氧化还原蛋白
- 批准号:
3306756 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
NOVEL REDOX PROTEINS FROM SULFATE REDUCING BACT
来自硫酸盐还原菌的新型氧化还原蛋白
- 批准号:
3306758 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
Biosynthesis and Novel Function of Fe-S clusters
Fe-S团簇的生物合成和新功能
- 批准号:
6918157 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
Biosynthesis and Novel Function of Fe-S clusters
Fe-S团簇的生物合成和新功能
- 批准号:
7393155 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Cystathionine Gamma Lyase (CSE) and Hydrogen Sulfide Regulation of Vascular Aging
胱硫醚γ裂解酶 (CSE) 和硫化氢对血管老化的调节
- 批准号:
10715408 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Development of amine-dehydrogenase and lyase biocatalysts for the sustainable manufacturing of unnatural chiral amino acids and amino alcohols
开发胺脱氢酶和裂解酶生物催化剂,用于可持续生产非天然手性氨基酸和氨基醇
- 批准号:
2870226 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Studentship
Deciphering the roles of cystathionine gamma-lyase/H2S system in Fe-S protein biogenesis and iron homeostasis
解读胱硫醚γ-裂解酶/H2S系统在Fe-S蛋白生物发生和铁稳态中的作用
- 批准号:
RGPIN-2022-05369 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Discovery Grants Program - Individual
Neuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signaling
胱硫醚 G-裂解酶通过气体递质硫化氢信号传导的神经保护作用
- 批准号:
10445502 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Neuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signaling
胱硫醚 G-裂解酶通过气体递质硫化氢信号传导的神经保护作用
- 批准号:
10614053 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Metabolic regulation and inhibition of ATP-citrate lyase
ATP-柠檬酸裂解酶的代谢调节和抑制
- 批准号:
10588229 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Targeting ATP-citrate lyase (ACLY) to overcome therapy resistance in breast cancer and melanoma
靶向 ATP-柠檬酸裂解酶 (ACLY) 以克服乳腺癌和黑色素瘤的治疗耐药性
- 批准号:
10580197 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
- 批准号:
10515118 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Metabolic regulation and inhibition of ATP-citrate lyase
ATP-柠檬酸裂解酶的代谢调节和抑制
- 批准号:
10444160 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
- 批准号:
10705139 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:














{{item.name}}会员




